ATE254473T1 - Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate - Google Patents

Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate

Info

Publication number
ATE254473T1
ATE254473T1 AT99963636T AT99963636T ATE254473T1 AT E254473 T1 ATE254473 T1 AT E254473T1 AT 99963636 T AT99963636 T AT 99963636T AT 99963636 T AT99963636 T AT 99963636T AT E254473 T1 ATE254473 T1 AT E254473T1
Authority
AT
Austria
Prior art keywords
hibitor
kunitz
accelerate
rate
serine protease
Prior art date
Application number
AT99963636T
Other languages
English (en)
Inventor
Roderick Hall
Christopher T Poll
Benjamin B Newton
William J A Taylor
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE254473T1 publication Critical patent/ATE254473T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT99963636T 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate ATE254473T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21891398A 1998-12-22 1998-12-22
US44196699A 1999-11-17 1999-11-17
PCT/GB1999/004381 WO2000037099A2 (en) 1998-12-22 1999-12-22 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor

Publications (1)

Publication Number Publication Date
ATE254473T1 true ATE254473T1 (de) 2003-12-15

Family

ID=26913378

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03018789T ATE407694T1 (de) 1998-12-22 1999-12-22 Methode zur beschleunigung der schleimauflöserate
AT99963636T ATE254473T1 (de) 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03018789T ATE407694T1 (de) 1998-12-22 1999-12-22 Methode zur beschleunigung der schleimauflöserate

Country Status (13)

Country Link
US (1) US20070086956A1 (de)
EP (2) EP1140150B1 (de)
JP (2) JP3819239B2 (de)
CN (1) CN1229138C (de)
AR (1) AR030257A1 (de)
AT (2) ATE407694T1 (de)
AU (1) AU758832B2 (de)
CA (1) CA2356404C (de)
DE (2) DE69912988T2 (de)
DK (2) DK1374891T3 (de)
ES (2) ES2318075T3 (de)
TW (1) TWI249406B (de)
WO (1) WO2000037099A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
CN1332715C (zh) * 2003-09-09 2007-08-22 王继峰 蛋白酶抑制剂在制备预防和治疗肺部疾病的药物中的用途
EP1586587A1 (de) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Zusammensetzungen und Verfahren zum Nachweis der Angiogenese
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
CN100408094C (zh) * 2005-08-29 2008-08-06 吉林圣元科技有限责任公司 蛋白酶抑制剂在保护肝细胞功能中的应用
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
WO2013175007A1 (en) * 2012-05-25 2013-11-28 Inserm Agents for treating cystic fibrosis
JP2016204360A (ja) * 2015-02-25 2016-12-08 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
ES2066033T3 (es) * 1989-05-13 1995-03-01 Bayer Ag Inhibidores de las proteinasas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
DE573603T1 (de) * 1991-03-01 1999-05-06 Dyax Corp Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g.
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
IL104325A (en) * 1992-01-07 2000-10-31 Novo Nordisk As Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
WO1994001461A1 (en) * 1992-07-13 1994-01-20 Corvas International, Inc. BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa
US5436153A (en) * 1992-12-02 1995-07-25 Sprecher; Cindy A. Human amyloid protein precursor homolog and Kunitz-type inhibitor
AU5684594A (en) * 1992-12-02 1994-06-22 Novo Nordisk A/S Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2769083B2 (ja) * 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
WO1995021601A2 (en) * 1994-01-11 1995-08-17 Protein Engineering Corporation Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
EP0758682B1 (de) * 1995-07-24 2004-05-12 Mitsubishi Chemical Corporation Inhibitor des Hepatozytwachstumsfaktoraktivators
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
HU226419B1 (en) * 1996-03-11 2008-12-29 Aerovance Human bikunin
US20070140979A1 (en) * 1998-12-22 2007-06-21 Bayer Aktiengesellschaft Method for accelerating the rate of mucociliary clearance

Also Published As

Publication number Publication date
DK1140150T3 (da) 2004-03-22
TWI249406B (en) 2006-02-21
DE69912988D1 (de) 2003-12-24
DE69912988T2 (de) 2004-11-11
CN1334743A (zh) 2002-02-06
AU1987800A (en) 2000-07-12
CA2356404A1 (en) 2000-06-29
ES2318075T3 (es) 2009-05-01
EP1374891A1 (de) 2004-01-02
JP2006232810A (ja) 2006-09-07
DK1374891T3 (da) 2009-01-26
EP1374891B1 (de) 2008-09-10
AR030257A1 (es) 2003-08-20
CN1229138C (zh) 2005-11-30
JP3819239B2 (ja) 2006-09-06
EP1140150A2 (de) 2001-10-10
DE69939559D1 (de) 2008-10-23
ES2209542T3 (es) 2004-06-16
CA2356404C (en) 2010-03-30
JP2002532558A (ja) 2002-10-02
US20070086956A1 (en) 2007-04-19
EP1140150B1 (de) 2003-11-19
WO2000037099A2 (en) 2000-06-29
WO2000037099A3 (en) 2000-10-26
ATE407694T1 (de) 2008-09-15
AU758832B2 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
NO20011966D0 (no) Serin-protease-inhibitor
NO20013850D0 (no) Sulfamat hydroksansyremetallproteaseinhibitor
FR15C0090I2 (fr) Solutions et procede d'irrigation ophtalmologique
NO20011968D0 (no) (Substituert)acyl-dipeptidyl-inhibitorer av ICE/ced-3- familien av cystein-proteaser
ATE219057T1 (de) Bisulfatsalz eines hiv-protease-inhibitors
NO992734L (no) Serin-protease inhibitorer
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
NO975742D0 (no) Reversible cysteinproteasehemmere
FI943234A (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
ATE345136T1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino- pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
DE69921129D1 (de) Intravaskulärer stent zum überbrücken eines aneurysmas
DE69827849D1 (de) Beschlagverhindernde gesichtsmaske
NO983688D0 (no) Serin-protease-inhibitorer
DE69730871D1 (de) Serine-protease-inhibitoren
ITRM20000425A0 (it) Metodo per ripristinare la stabilita' di un modulatore sigma-delta e circuito per mettere in pratica tale metodo.
ATE221080T1 (de) Serine-protease-inhibitoren
ATE254473T1 (de) Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate
DE50114021D1 (de) Stabilisierte Flüssigzubereitung der den Blutgerinnungsfaktor VII aktivierenden Protease oder ihres Proenzyms
FI962073A (fi) HIV-proteaasin estäjän prodrug-muotoja
FR2796732B1 (fr) Piece d'horlogerie a affichage du quantieme
DE60018173D1 (de) Giessform zur herstellung eines kühlelementes
NO20011388L (no) Hydroksamat-inneholdende cystein- og serinproteasehemmere
DE60033117D1 (de) Verhinderung des Festklebens von Hartkonfekten
ITMI20001216A0 (it) Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica
DE69715619D1 (de) Inhibition der matrix metalloproteasen durch 2-(omega-aroylalkyl)-4-biaryl-4-oxobutansäuren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140150

Country of ref document: EP

REN Ceased due to non-payment of the annual fee